^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    Flomics Biotech

    i
    Other names: Flomics Biotech
    Evidence

    News

    almost2years
    Flomics Biotech raises €1.1M for RNA-based multicancer test (Genomeweb)
    "Flomics Biotech said...that it closed a €1.1 million ($1.2 million) seed financing round...The Barcelona, Spain-based startup said that it plans to use the funds to advance the preclinical validation of its next-generation sequencing-based liquid biopsy assay. The test aims to provide early diagnosis of colorectal, lung, breast, prostate, and pancreatic cancer via circulating cell-free RNA."
    Financing